To evaluate the feasibility and limitations of measuring health-related social risks (HRSRs) affecting individuals in a lung cancer screening (LCS) cohort from multiple data sources.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Radiology Utilization in an Academic Center Partnership with a Federally Qualified Health Center: A Cross-Sectional Study
Federally qualified health centers (FQHC) serve medically underserved populations. In 2013, UW Health, the health system of the University of Wisconsin, partnered with Access Community Health Centers (ACHC), the FQHC network in Madison, WI to provide on-site outpatient imaging. This study characterized radiography utilization associated with the UW Health-ACHC partnership compared to other UW Health outpatient imaging sites.
-
Optellum, Bristol Myers Squibb to Leverage AI to Boost Early Lung Cancer Diagnosis
tim.hodson
Thu, 04/17/2025 – 16:25
April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and precision lung cancer care. Under the agreement, Optellum will apply its AI-powered imaging and clinical decision support platform to evaluate the real-world impact on patient outcomes.
Lung cancer remains the leading cause of cancer-related deaths worldwide, often going undetected until it reaches an advanced stage. Late-stage diag… -
Nanox gets FDA clearance for Nanox.ARC X system
Nanox has received 510(k) clearance from the U.S. FDA for the company’s new multisource digital tomosynthesis system.
-
CureMetrix Mammogram Software Expands FDA Clearance, Validated on GE, Hologic Platforms
tim.hodson
Thu, 04/17/2025 – 12:13
April 15, 2025 — CureMetrix, a provider of AI-driven medical imaging solutions, has announced that its AI-based cmAngio software received FDA clearance for use with GE Healthcare mammography imaging platforms. This builds on cmAngio’s initial FDA clearance for use with Hologic mammography imaging platforms.
FDA-cleared cmAngio is an AI-based software that reads mammograms and detects and localizes Breast Arterial Calcifications (BAC). cmAngio anal… -
FDA Clears Emerging Digital Tomosynthesis System
The Nanox.ARC X system reportedly provides enhanced 3D imaging for a variety of indications, ranging from pulmonary imaging and intra-abdominal views to musculoskeletal assessment.
-
U.S. Radiotherapy Market to Grow Nearly 5 Percent by 2030
tim.hodson
Thu, 04/17/2025 – 11:10
April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 with a CAGR of 4.6%.
The US radiotherapy market is growing due to ongoing technological innovations and appetite for faster adoption of novel techniques such as increasing use of SBRT (Stereotactic Body Radiation Therapy) and IGRT (Image-Guided Radiation Therapy), the rising R&D investment for cancer research, growing adoption o… -
Integrative Strategies in Palliative Care for MBC
The experts discuss integrative models in palliative care for MBC, highlighting the importance of multidisciplinary collaboration and personalized care strategies tailored to the individual’s needs. Medscape Oncology
-
Recent Mammography Screening in Seniors Associated with 54 Percent Lower Risk of Later-Stage Diagnosis
Seniors who had at least one prior screening mammography exam in the five years prior to breast cancer diagnosis were over a third less likely to die from breast cancer, according to new research.